Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Is there a viable role for anti-obesity drugs in the treatment of Type 2 diabetes?

April 26, 2017anti-obesity diabetes news drugs health news medical headlines medical news treatment type 2 diabetes viable

0

Posted

Is there a viable role for anti-obesity drugs in the treatment of Type 2 diabetes?

1 Answer

0

Posted

– The role of obesity as a key driver of the Type 2 diabetes epidemic. – A realistic assessment of the contribution of moderate weight-loss to improving glycaemic control in diabetic patients. – Combination therapy with anti-obesity and anti-diabetic drugs to maximize clinical benefit in the treatment of type 2 diabetes. – Routes to regulatory approval for metabolic drugs – obesity versus Type 2 diabetes Professor David Heal,Director,RenaSci Consultancy 16:20 Chair’s closing remarks 16:30 End of conference ***Booking your place*** 2 day Conference ticket – available for only GBP £1299 2 day Confernce ticket + worshop- available for only GBP £1699 Registration is simple! All you need to do to book your place is contact Justyna. TEL: +44 (0)207 549 9946 or email: justyna.drozdzal@visiongainglobal.